CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas

Previous researches have demonstrated the meaning of CTSB for the progress of several tumors, whereas few clues about its immunological characteristic in gliomas. Here we systematically explored its biologic features and clinical significance for gliomas. 699 glioma cases of TCGA and 325 glioma case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Kaiming, Chen, Xin, Liu, Weihai, Chen, Suhua, Yang, Chenlong, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917123/
https://www.ncbi.nlm.nih.gov/pubmed/35277559
http://dx.doi.org/10.1038/s41598-022-08346-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917123/
https://www.ncbi.nlm.nih.gov/pubmed/35277559
http://dx.doi.org/10.1038/s41598-022-08346-2

Ejemplares similares